Revive Therapeutics Collaborates with Attwill Medical Solutions for the Clinical and Commercial Development of a Novel Lyophilized Formulation of Bucillamine

TORONTO, Dec. 18, 2023 -- Revive Therapeutics Ltd. , a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to...

Related Keywords

Canada ,Toronto ,Ontario ,Waterloo ,Canadian ,Michael Frank ,Neither The Canadian Securities Exchange ,Attwill Medical Solutions ,Therapeutics Ltd ,University Of Waterloo ,Canadian Department Of National Defence ,Regulation Services Provider ,Defence Rd Canada ,Canadian Department ,National Defence ,Emergency Use Authorization ,Orphan Drug ,Fast Track ,Breakthrough Therapy ,Canadian Securities Exchange ,Markets ,